Xia Changfa, Ding Chao, Zheng Rongshou, Zhang Siwei, Zeng Hongmei, Wang Jinfeng, Liao Yilan, Zhang Ningxu, Yang Zhixun, Chen Wanqing
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China.
Chin J Cancer Res. 2017 Dec;29(6):487-495. doi: 10.21147/j.issn.1000-9604.2017.06.03.
This study was designed to explore the time trends in geographical variations of cervical cancer mortality in mainland China over the period 1973 to 2013, to provide subnational spatio-temporal patterns for targeted promotion of human papillomavirus vaccine in China.
Data were extracted from three national retrospective death surveys and cancer registry. The rate ratio (RR) was estimated for the aggregated data for seven geographical regions using generalized linear models to evaluate time trends in geographical disparities of cervical cancer mortality.
There was a significant decrease in cervical cancer mortality in China from 1973-1975 to 2004-2005, but leveled off thereafter to 2011-2013. Compared to the period 1973-1975 the RR for the three last time periods were 0.33 [95% confidence interval (95% CI): 0.30-0.37] for 1990-1992, 0.21 (95% CI: 0.19-0.24) for 2004-2005 and 0.24 (95% CI: 0.22-0.26) for 2011-2013. Females living in the Northwest China and Central China have a high risk of mortality from cervical cancer compared to the nationwide, with the RR being 2.09 (95% CI: 1.83-2.38) and 1.26 (95% CI: 1.11-1.44) respectively, while the RRs for South China, Northeast China and Southwest China were below 1.00, indicating the lower death risk. Despite the mortality rate had increased slightly from 2004 to 2013, there was an encouraging sign that the geographical disparities in cervical cancer mortality had gradually narrowed over time across China.
Although cervical cancer mortality in China has reduced to very low levels, the high risk of cervical cancer in Northwest China and Central China is still noteworthy. Public health policies including the promotion of vaccine should be targeted to further reduction of geographical disparities in cervical cancer mortality.
本研究旨在探讨1973年至2013年中国大陆宫颈癌死亡率的地理差异随时间的变化趋势,为中国针对性推广人乳头瘤病毒疫苗提供国家以下层面的时空模式。
数据取自三项全国性回顾性死亡调查和癌症登记处。使用广义线性模型对七个地理区域的汇总数据估计率比(RR),以评估宫颈癌死亡率地理差异的时间趋势。
从1973 - 1975年到2004 - 2005年,中国宫颈癌死亡率显著下降,但此后至2011 - 2013年趋于平稳。与1973 - 1975年相比,最后三个时间段的RR分别为:1990 - 1992年为0.33 [95%置信区间(95%CI):0.30 - 0.37],2004 - 2005年为0.21(95%CI:0.19 - 0.24),2011 - 2013年为0.24(95%CI:0.22 - 0.26)。与全国相比,居住在中国西北和中部的女性宫颈癌死亡风险较高,RR分别为2.09(95%CI:1.83 - 2.38)和1.26(95%CI:1.11 - 1.44),而华南、东北和西南地区的RR低于1.00,表明死亡风险较低。尽管2004年至2013年死亡率略有上升,但令人鼓舞的是,随着时间推移,中国宫颈癌死亡率的地理差异逐渐缩小。
尽管中国宫颈癌死亡率已降至非常低的水平,但中国西北和中部地区宫颈癌的高风险仍然值得关注。包括推广疫苗在内的公共卫生政策应旨在进一步缩小宫颈癌死亡率的地理差异。